logo logo


Honest approach required in Korea-U.S. FTA negotiation
I read an article by Woo Seok-gyun, an official from the Korea Federation of Medical Groups for Health Rights (KFHR), regarding the Korea-U.S. Free Trade Agreement (FTA) negotiation on medical care and education. Mr. Woo described the upcoming negotiation as a ’game of truth’ by the government.
US drug company appeals PBS decision
It’s just over a year since the Australia US Free Trade Agreement came into force, opening the door for US drug companies to force a review of decisions about which drugs are subsidised by the Australian Government. Now that power is being used by the US drug company Eli Lilly.
A US Free Trade Agreement could threaten access to medicine in Thailand
New stringent drug patent and marketing rules being negotiated in a Free Trade Agreement (FTA) between the US and Thailand would limit competition and reduce access to affordable medicines in Thailand.
US-FTA blocks medicine for many
The Guatemalan pharmaceutical industry is the strongest company in Central America and among the first 10 in Latin America, but it is today threatened by the free trade agreement (FTA) with United States.
Trade-related intellectual property rights, access to medicines and human rights - Morocco
The briefing calls for an independent human rights impact assessment of the effect of intellectual property rules in the US-Morocco Free Trade Agreement (FTA) on access to medicines and the enjoyment of human rights in Morocco.
US-Peru free trade deal a step back for development
International aid organization Oxfam criticized today’s signing of the US-Peru Free Trade Agreement (FTA) in Washington, an agreement it says would do more harm than good for millions of Peruvians who live in poverty.
US pushes to limit generic drug rights
Under global trading rules, the inventors of medicines ordinarily enjoy the right to a 20-year monopoly on their inventions. But five years ago, the United States joined 141 other countries to sign the Doha Declaration, confirming the right of poor countries to break drug patents and produce cheap generic drugs in the event of contagions like HIV.
US biotech deal blazes Aussie trail
At just $4million, it’s hardly the biggest biotech deal ever struck by an Australian company, but it’s an important first.
The US-Peru Trade Promotion Agreement (TPA): The intellectual property provisions
Report of the US government’s Industry Trade Advisory Committee on Intellectual Property Rights (ITAC-15)
FTA Watch statement: In support of Korean people’s struggle against the Korea-US FTA
Although Thailand and South Korea are different in terms of development, people in both countries share a common demand for the protection of their right to affordable medicines and treatment.
Rural Pharmacists call to oust Thaksin
The Rural Pharmacists Club issued a statement on Sunday calling for caretaker Prime Minister Thaksin Shinawatra to resign and said the prime minister should face an investigation by independent committee over his alleged attempts to amend law to allow foreign companies to take over the country’s vital state enterprises.
South African Custom Union planning for FTA with India
The South African Customs Union is in talks with the Indian government for signing a Free Trade Agreement (FTA) to enhance the trade and business between both the countries.
Appeal for Malaysians to have access to affordable medicines
Open letter to Prime Minister Datuk Seri Abdullah Ahmad Badawi
Tripping up TRIPs debates
Access to medicine is at the forefront of multilateral debates surrounding the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs). This paper argues that bilateralism allows the United States to circumvent these debates and to set standards that serve and protect the pharmaceutical industry.
US-Thailand: Talks could slow over plant and drug issues
Differences over pharmaceuticals could be overcome, but the countries are far from reaching a common understanding on biodiversity issues.
‘Secret’ FTA details on the Net
Details of US proposals in free-trade talks with Thailand - perceived by many Thais as “forbidden information” the government has tried to cover up - were recently posted for all to see in cyberspace. Witoon Leanchamroon, director of BioThai, a non-government organisation working for bio-diversity and community rights, said at a press conference yesterday he had been told a group of Americans involved in public health issues had posted a full text of the patent chapter from the Thai-US free trade talks at
EDITORIAL: Health at stake in free-trade talks
For the United States, intellectual property rights represent the single most valuable asset in light of the new reality of information-based economies and where they derive their national wealth. The supremacy of the US as a global power depends on how effective it is in acquiring and maintaining its ownership of knowledge assets.
Draft amendment to patent law a ’sell-out’
Opponents of a free trade area (FTA) agreement with the US have lashed out at the government’s proposed amendment of Thai patent law to facilitate the United States’ patenting of drugs and living organisms in Thailand. They fear it would lead to greater control of the country’s resources by American firms.
Myths and realities: The impact of the US-Thai FTA on access to medicines
Reeling from the negative publicity and pro-access to medicines messaging in Thailand and internationally, the Office of the US Trade Representative (USTR) has mounted a public relations campaign full of distortions and omissions.
Free trade with US will hurt health care
Will the hands that save the lives of Thailand’s sick be tied once a free trade deal between this country and the United States is signed, later this year?